Therefore, to impede this pressing trend, it is essential to realize the early diagnosis and therapeutics of prostate cancer for which prostate specific antigen (PSA) has been the most extensively applied directional tumor marker [3]. This evidence concerns the gene KLK3 and prostate carcinoma.